Corvus Pharmaceuticals (CRVS) EBT (QoQ) (2015 - 2025)
Corvus Pharmaceuticals (CRVS) EBT (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -29.24% |
| Jun 30, 2025 | -148.37% |
| Sep 30, 2024 | -972.86% |
| Jun 30, 2024 | 37.93% |
| Mar 31, 2024 | -3.58% |
| Dec 31, 2023 | -11.63% |
| Sep 30, 2023 | 1.61% |
| Jun 30, 2023 | 15.03% |
| Mar 31, 2023 | -6.30% |
| Dec 31, 2022 | 54.44% |
| Sep 30, 2022 | -72.62% |
| Jun 30, 2022 | 6.24% |
| Mar 31, 2022 | -8.47% |
| Dec 31, 2021 | 23.74% |
| Sep 30, 2021 | 19.07% |
| Jun 30, 2021 | 1.61% |
| Mar 31, 2021 | -16.01% |
| Dec 31, 2020 | -0.78% |
| Sep 30, 2020 | 7.42% |
| Jun 30, 2020 | 17.46% |